Jefferies Lifts Price Target on Amgen (NASDAQ:AMGN) to $310 From $275

By / / Amgen, Jefferies

Jefferies Lifts Price Target on Amgen (NASDAQ:AMGN) to $310 From $275, Maintains Buy Rating.

Scroll to Top